Nachrichten zur Johnson & Johnson Aktie

Johnson & Johnson (JNJ) Up 5.3% Since Last Earnings Report: Can It Continue?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Johnson & Johnson stock rises Wednesday, outperforms market

Johnson & Johnson stock rises Wednesday, outperforms market...…

Sea, UiPath, J&J Snack Foods And Other Big Gainers From Tuesday

U.S. stocks closed higher on Tuesday, with the Nasdaq Composite gaining more than 150 points. Here is the list of…

J&J; Snack Foods (JJSF) Q4 2022 Earnings Call Transcript

JJSF earnings call for the period ending September 30, 2022....…

Johnson & Johnson stock rises Tuesday, still underperforms market

Johnson & Johnson stock rises Tuesday, still underperforms market...…

J&J Snack Foods Non-GAAP EPS of $1.05 beats by $0.10, revenue of $400.43M beats by $16.54M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson stock outperforms market on strong trading day

Johnson & Johnson stock outperforms market on strong trading day...…

Dow flat despite gains in shares of Merck, Johnson & Johnson

Dow flat despite gains in shares of Merck, Johnson & Johnson...…

Dows 100-point jump highlighted by gains in Merck, Johnson & Johnson stocks

Dow's 100-point jump highlighted by gains in Merck, Johnson & Johnson stocks...…

Dows 190-point climb highlighted by gains for shares of Merck, Johnson & Johnson

Dow's 190-point climb highlighted by gains for shares of Merck, Johnson & Johnson...…

Dow jumps nearly 100 points on gains in Merck, Johnson & Johnson stocks

Dow jumps nearly 100 points on gains in Merck, Johnson & Johnson stocks...…

3 takeaways from our daily meeting: Bullish on JNJ, AMD upgrades, Disney cost cuts

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET....…

Blitz-Update: Dow & Co nach Rally stabil – Pharmawerte im Fokus, Merck & Co, Johnson & Johnson, Biogen Top-Gewinner, Apple und Microsoft mit Verlusten

Nach der jüngsten Rally herrscht am Montag an den US-Börsen Zurückhaltung. Zugleich aber zeigen sich die Anleger recht entspannt. Der…

Johnson & Johnson stock underperforms Friday when compared to competitors

Johnson & Johnson stock underperforms Friday when compared to competitors...…

J&J analysis: Early Tremfya efficacy in psoriatric arthritis can predict long-term response

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?

Learn more about Organicell Regenerative Medicine, Inc.from this latest report.During the peak of the deadly COVID-19 pandemic, one novel therapeutic…

Better Buy: Johnson & Johnson vs. Abbott Laboratories

These two healthcare giants are among the safest stocks investors can buy right now....…

Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed

The company is planting seeds for future growth....…

CNBC Stock World Cup: United Healthcare vs Johnson & Johnson and Netflix vs Disney — who wins?

Heading into the World Cup season, CNBC spoke to Chuck Lieberman of Advisors Capital Management on whether United Healthcare or…

Insiderhandel: Exec VP, WW Chair, Consumer verkauft Aktien von Johnson & Johnson im Wert von 6.033.305$

Mongon, Thibaut - Vorstand - Tag der Transaktion: 2022-11-04...…

Johnson & Johnson stock rises Tuesday, still underperforms market

Johnson & Johnson stock rises Tuesday, still underperforms market...…

SciBase invitation to a webinar on November 10 at 11:00 CET

STOCKHOLM, SWEDEN - November 8, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin…

SciBase CEO Simon Grant gives a comment regarding the collaboration with Johnson & Johnson Consumer Health

STOCKHOLM, Nov. 8, 2022 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO:SCIB), a leading developer of augmented intelligence-based solutions for skin…

SciBase CEO Simon Grant gives a comment regarding the collaboration with Johnson & Johnson Consumer Health

STOCKHOLM, SWEDEN - November 8, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin…

SciBase announces collaboration to detect skin barrier dysfunction in infants

STOCKHOLM, Nov. 8, 2022 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for…

Johnson & Johnson stock rises Monday, still underperforms market

Johnson & Johnson stock rises Monday, still underperforms market...…

Former J&J exec no longer seen as frontrunner for Biogen CEO position - STAT

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

SciBase announces collaboration to detect skin barrier dysfunction in infants

November 7, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today…

Beat the Dow Jones With This Unstoppable Dividend Stock

Johnson & Johnson has outperformed the Dow so far this year....…

Johnson & Johnson stock rises Friday, still underperforms market

Johnson & Johnson stock rises Friday, still underperforms market...…

J&J Makes a $16.6 Billion Bet on Heart Pumps to Lift Medical-Device Sales

J&J wanted a deal to boost its medical-device division, which will become more important after the company sheds its consumer-health…

Is Johnson & Johnson an Underrated Growth Stock?

Johnson & Johnson trades at a modest earnings multiple, and it may warrant a premium....…

Hot Stocks: VRNS, ZBRA plunge on earnings; IDXX climbs; ABMD surges 50% on JNJ merger deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

SHAREHOLDER ALERT: Weiss Law Investigates Abiomed, Inc.

NEW YORK, Nov. 1, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of…

Health Care Up on J&J Deal, Pfizer Earnings -- Health Care Roundup

Health Care Up on J&J Deal, Pfizer Earnings -- Health Care Roundup...…

Johnson & Johnson: Multi-Milliarden-Deal sorgt für Aufsehen - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Benjamin Heimlich vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…

J&J Agrees to Buy Heart-Device Maker Abiomed for $16.6 Billion

The deal would add heart pumps, a fast-growing part of the medical-device industry, to the J&J lineup....…

J&J kauft Medizintechnik ein

Um den gesamten Artikel unter boersen-zeitung.de zu lesen, klicken Sie bitte auf die Überschrift...…

Abiomed unlikely to see higher bid given size of J&J premium - analyst

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pre-Markets Up Ahead of New Fed Hike, Q3 Beats

Big Pharma giants Pfizer (PFE) and Lilly (LLY) posted beats on both top and bottom lines this morning, while J&J…

Johnson & Johnson: Kurssprung nach Übernahme-Ankündigung

Nachdem bislang eher mauen M&A-Jahr im Medtech-Sektor sorgt Johnson & Johnson am Dienstag mit einem Multi-Milliarden-Deal für Aufsehen. Der Konzern…

Shareholder Alert: Ademi LLP investigates whether ABIOMED, Inc. has obtained a Fair Price in its transaction with Johnson & Johnson

MILWAUKEE, Nov. 1, 2022 /PRNewswire/ -- Ademi LLP is investigating ABIOMED (NASDAQ: ABMD) for possible breaches of fiduciary duty and…

dpa-AFX ProFeed